XML 75 R60.htm IDEA: XBRL DOCUMENT v3.24.1
Contingent consideration 1 - Summary of liabilities - contingent consideration (Detail) - AUD ($)
Dec. 31, 2023
Jun. 30, 2023
Disclosure of contingent liabilities [line items]    
Contingent consideration, non-current $ 5,559,989 $ 6,120,783
Contingent consideration — Paxalisib [Member]    
Disclosure of contingent liabilities [line items]    
Contingent consideration, non-current 750,499 653,692
Contingent consideration — EVT801 [Member]    
Disclosure of contingent liabilities [line items]    
Contingent consideration, non-current $ 4,809,490 $ 5,467,091